Cassava Sciences, Inc. vs Pharmicell Co., Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pharmicell Co., Ltd. is the larger company by market value: $514 M against $115 M for Cassava Sciences, Inc., 4.5 times as much (market caps of Aug 1, 2026). Cassava Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Cassava Sciences, Inc. SAVA · #18,221 in the world | Pharmicell Co., Ltd. 005690.KS · #12,408 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇰🇷 South Korea |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 1998 | — |
| Size | ||
| Market cap | $115 M | $514 M |
| Revenue | $0 M | — |
| Net income | $-76 M | — |
| Valuation | ||
| Price to book | 0.5× | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Aug 2026 | Market cap Aug 2026 |
Questions and answers#
Which is bigger, Cassava Sciences, Inc. or Pharmicell Co., Ltd.?
Pharmicell Co., Ltd. is the larger company by market value: $514 M against $115 M for Cassava Sciences, Inc., 4.5 times as much (market caps of Aug 1, 2026). Cassava Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.